Crystal Structure of Human Interferon-γ1 in Complex with Its High-Affinity Receptor Interferon-γR1

Journal of Molecular Biology

Volumn 404, Issue 4, 2010, Pages 650-664

  Miknis, Zachary J ^a   Magracheva, Eugenia ^a,b   Li, Wei ^c   Zdanov, Alexander ^a   Kotenko, Sergei V ^c   Wlodawer, Alexander ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c University of Medicine and Dentistry of New Jersey   (United States)

Author keywords

Antiviral; Crystallography; Cytokine; Immunity; Signaling

Indexed keywords

CYTOKINE; FIBRONECTIN; GAMMA INTERFERON RECEPTOR 1; HUMAN INTERFERON; INTERLEUKIN 10;

AMINO TERMINAL SEQUENCE; ARTICLE; CRYSTAL STRUCTURE; HINGE REGION; HUMAN; HYDROGEN BOND; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN STRUCTURE; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 78549295146     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.09.068     Document Type: Article

References (66)

1. Kotenko S.V., Langer J.A. Full house: 12 receptors for 27 cytokines. Int. Immunopharmacol. 2004, 4:593-608.
2. Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes A., Shen M., Shah N.K., et al. IFN-γs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 2003, 4:69-77.
3. Sheppard P., Kindsvogel W., Xu W., Henderson K., Schlutsmeyer S., Whitmore T.E., et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 2003, 4:63-68.
4. Meager A., Visvalingam K., Dilger P., Bryan D., Wadhwa M. Biological activity of interleukins-28 and -29: comparison with type I interferons. Cytokine 2005, 31:109-118.
5. Robek M.D., Boyd B.S., Chisari F.V. Lambda interferon inhibits hepatitis B and C virus replication. J. Virol. 2005, 79:3851-3854.
6. Marcello T., Grakoui A., Barba-Spaeth G., Machlin E.S., Kotenko S.V., MacDonald M.R., Rice C.M. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 2006, 131:1887-1898.
7. Mordstein M., Neugebauer E., Ditt V., Jessen B., Rieger T., Falcone V., et al. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J. Virol. 2010, 84:5670-5677.
8. Ank N., West H., Bartholdy C., Eriksson K., Thomsen A.R., Paludan S.R. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J. Virol. 2006, 80:4501-4509.
9. Brand S., Beigel F., Olszak T., Zitzmann K., Eichhorst S.T., Otte J.M., et al. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am. J. Physiol.: Gastrointest. Liver Physiol. 2005, 289:G960-G968.
10. Doyle S.E., Schreckhise H., Khuu-Duong K., Henderson K., Rosler R., Storey H., et al. Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology 2006, 44:896-906.
11. Zhou J., Lu L., Yuen M.F., Lam T.W., Chung C.P., Lam C.L., et al. Polymorphisms of type I interferon receptor 1 promoter and their effects on chronic hepatitis B virus infection. J. Hepatol. 2007, 46:198-205.
12. Pestka S., Krause C.D., Sarkar D., Walter M.R., Shi Y., Fisher P.B. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 2004, 22:929-979.
13. Lasfar A., Lewis-Antes A., Smirnov S.V., Anantha S., Abushahba W., Tian B., et al. Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma. Cancer Res. 2006, 66:4468-4477.
14. Sommereyns C., Michiels T. N-glycosylation of murine IFN-beta in a putative receptor-binding region. J. Interferon Cytokine Res. 2006, 26:406-413.
15. Cutrone E.C., Langer J.A. Identification of critical residues in bovine IFNAR-1 responsible for interferon binding. J. Biol. Chem. 2001, 276:17140-17148.
16. Yoon S.I., Jones B.C., Logsdon N.J., Walter M.R. Same structure, different function crystal structure of the Epstein-Barr virus IL-10 bound to the soluble IL-10R1 chain. Structure 2005, 13:551-564.
17. Zitzmann K., Brand S., Baehs S., Goke B., Meinecke J., Spottl G., et al. Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells. Biochem. Biophys. Res. Commun. 2006, 344:1334-1341.
18. Li Q., Kawamura K., Ma G., Iwata F., Numasaki M., Suzuki N., et al. Interferon-lambda induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents. Eur. J. Cancer 2010, 46:180-190.
19. Li W., Lewis-Antes A., Huang J., Balan M., Kotenko S.V. Regulation of apoptosis by type III interferons. Cell Proliferation 2008, 41:960-979.
20. Guenterberg K.D., Grignol V.P., Raig E.T., Zimmerer J.M., Chan A.N., Blaskovits F.M., et al. Interleukin-29 binds to melanoma cells inducing Jak-STAT signal transduction and apoptosis. Mol. Cancer Ther. 2010, 9:510-520.
21. Numasaki M., Tagawa M., Iwata F., Suzuki T., Nakamura A., Okada M., et al. IL-28 elicits antitumor responses against murine fibrosarcoma. J. Immunol. 2007, 178:5086-5098.
22. Sato A., Ohtsuki M., Hata M., Kobayashi E., Murakami T. Antitumor activity of IFN-lambda in murine tumor models. J. Immunol. 2006, 176:7686-7694.
23. Abushahba W., Balan M., Castaneda I., Yuan Y., Reuhl K., Raveche E., et al. Antitumor activity of type I and type III interferons in BNL hepatoma model. Cancer Immunol. Immunother. 2010, 59:1059-1071.
24. Dellgren C., Gad H.H., Hamming O.J., Melchjorsen J., Hartmann R. Human interferon-lambda3 is a potent member of the type III interferon family. Genes Immun. 2009, 10:125-131.
25. Kotenko S.V. IFN-γs. Class II Cytokines 2007, 201-211. Transworld Research Network, Kerala, India. A. Zdanov (Ed.).
26. Langer J.A. Type I interferons: something old, something new. Class II Cytokines 2007, 15-49. Transworld Research Network, Kerala, India. A. Zdanov (Ed.).
27. Zdanov A. Classification and known structures of class II cytokines. Class II Cytokines 2007, 1-14. Transworld Research Network, Kerala, India.
28. Yoon S.I., Jones B.C., Logsdon N.J., Harris B.D., Deshpande A., Radaeva S., et al. Structure and mechanism of receptor sharing by the IL-10R2 common chain. Structure 2010, 18:638-648.
29. Gad H.H., Dellgren C., Hamming O.J., Vends S., Paludan S.R., Hartmann R. Interferon-{lambda} is functionally an interferon but structurally related to the interleukin-10 family. J. Biol. Chem. 2009, 284:20869-20875.
30. Xu T., Logsdon N.J., Walter M.R. Structure of insect-cell-derived IL-22. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2005, 61:942-950.
31. Walter M.R., Nagabhushan T.L. Crystal structure of interleukin 10 reveals an interferon gamma-like fold. Biochemistry 1995, 34:12118-12125.
32. Zdanov A., Schalk-Hihi C., Gustchina A., Tsang M., Weatherbee J., Wlodawer A. Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon ?. Structure 1995, 3:591-601.
33. Zdanov A., Schalk-Hihi C., Wlodawer A. Crystal structure of human interleukin-10 at 1.6 Å resolution and a model of a complex with its soluble receptor. Protein Sci. 1996, 5:1955-1962.
34. Pletnev S., Magracheva E., Wlodawer A., Zdanov A. A model of the ternary complex of interleukin-10 with its soluble receptors. BMC Struct. Biol. 2005, 5:10.
35. Josephson K., Logsdon N.J., Walter M.R. Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site. Immunity 2001, 15:35-46.
36. Jones B.C., Logsdon N.J., Josephson K., Cook J., Barry P.A., Walter M.R. Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1. Proc. Natl Acad. Sci. USA 2002, 99:9404-9409.
37. Chang C., Magracheva E., Kozlov S., Fong S., Tobin G., Kotenko S., et al. Crystal structure of interleukin-19 defines a new subfamily of helical cytokines. J. Biol. Chem. 2003, 278:3308-3313.
38. Nagem R.A.P., Colau D., Dumoutier L., Renauld J.C., Ogata C., Polikarpov I. Crystal structure of recombinant human interleukin-22. Structure 2002, 10:1051-1062.
39. Bleicher L., de Moura P.R., Watanabe L., Colau D., Dumoutier L., Renauld J.C., Polikarpov I. Crystal structure of the IL-22/IL-22R1 complex and its implications for the IL-22 signaling mechanism. FEBS Lett. 2008, 582:2985-2992.
40. Jones B.C., Logsdon N.J., Walter M.R. Structure of IL-22 bound to its high-affinity IL-22R1 chain. Structure 2008, 16:1333-1344.
41. de Moura P.R., Watanabe L., Bleicher L., Colau D., Dumoutier L., Lemaire M.M., et al. Crystal structure of a soluble decoy receptor IL-22BP bound to interleukin-22. FEBS Lett. 2009, 583:1072-1077.
42. Suppiah V., Moldovan M., Ahlenstiel G., Berg T., Weltman M., Abate M.L., et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat. Genet. 2009, 41:1100-1104.
43. Thomas D.L., Thio C.L., Martin M.P., Qi Y., Ge D., O'hUigin C., et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009, 461:798-801.
44. Ge D., Fellay J., Thompson A.J., Simon J.S., Shianna K.V., Urban T.J., et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009, 461:399-401.
45. Thompson A.J., Muir A.J., Sulkowski M.S., Ge D., Fellay J., Shianna K.V., et al. Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus. Gastroenterology 2010, 139:120-129.
46. Tanaka Y., Nishida N., Sugiyama M., Kurosaki M., Matsuura K., Sakamoto N., et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat. Genet. 2009, 41:1105-1109.
47. Magracheva E., Pletnev S., Kotenko S., Li W., Wlodawer A., Zdanov A. Purification, crystallization and preliminary crystallographic studies of the complex of interferon-lambda1 with its receptor. Acta Crystallogr. Sect. F: Struct. Biol. Cryst. Commun. 2010, 66:61-63.
48. Presnell S.R., Cohen F.E. Topological distribution of four-α-helix bundles. Proc. Natl Acad. Sci. USA 1989, 86:6592-6596.
49. Bairoch A., Boeckmann B., Ferro S., Gasteiger E. Swiss-Prot: juggling between evolution and stability. Brief. Bioinform. 2004, 5:39-55.
50. Leahy D.M., Hendrickson W.A., Aukhuil E., Erickson H.P. Structure of a fibronectin type III domain from tenascin phased by MAD analysis of selenomethionyl protein. Science 1992, 258:987-991.
51. Walter M.R., Windsor W.T., Nagabhushan T.L., Lundell D.J., Lunn C.A., Zauodny P.J., Narula S.K. Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor. Nature 1995, 376:230-235.
52. Lawrence M.C., Colman P.M. Shape complementarity at protein/protein interfaces. J. Mol. Biol. 1993, 234:946-950.
53. Josephson K., Jones B.C., Walter L.J., DiGiacomo R., Indelicato S.R., Walter M.R. Noncompetitive antibody neutralization of IL-10 revealed by protein engineering and x-ray crystallography. Structure 2002, 10:981-987.
54. Landar A., Curry B., Parker M.H., DiGiacomo R., Indelicato S.R., Nagabhushan T.L., et al. Design, characterization, and structure of a biologically active single-chain mutant of human IFN-gamma. J. Mol. Biol. 2000, 299:169-179.
55. Karpusas M., Nolte M., Benton C.B., Meier W., Lipscomb W.N., Goelz S. The crystal structure of human interferon beta at 2.2-Å resolution. Proc. Natl Acad. Sci. USA 1997, 94:11813-11818.
56. Huang J., Smirnov S.V., Lewis-Antes A., Balan M., Li W., Tang S., et al. Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Proc. Natl Acad. Sci. USA 2007, 104:9822-9827.
57. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997, 276:307-326.
58. McCoy A.J. Solving structures of protein complexes by molecular replacement with Phaser. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2007, 63:32-41.
59. Adams P.D., Grosse-Kunstleve R.W., Hung L.W., Ioerger T.R., McCoy A.J., Moriarty N.W., et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. Sect. D: Biol. Crystallogr. 2002, 58:1948-1954.
60. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D: Biol. Crystallogr. 2004, 60:2126-2132.
61. Davis I.W., Murray L.W., Richardson J.S., Richardson D.C. MolProbity: structure validation and all-atom contact analysis for nucleic acids and their complexes. Nucleic Acids Res. 2004, 32:W615-W619.
62. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., et al. The Protein Data Bank. Nucleic Acids Res. 2000, 28:235-242.
63. Krissinel E., Henrick K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 2007, 372:774-797.
64. Laskowski R.A. PDBsum new things. Nucleic Acids Res. 2009, 37:D355-D359.
65. Holm L., Kaariainen S., Rosenstrom P., Schenkel A. Searching protein structure databases with DaliLite v.3. Bioinformatics 2008, 24:2780-2781.
66. DeLano W.L. The PyMOL Molecular Graphics System 2002, DeLano Scientific, San Carlos, CA.